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Risk factors for melanoma include environmental
(particularly ultraviolet exposure) and genetic
factors. In rare families, susceptibility to melanoma
is determined by high penetrance mutations in the
genes CDKN2A or CDK4, with more common, less
penetrant genes also postulated. A further, potent
risk factor for melanoma is the presence of large
numbers of melanocytic nevi so that genes control-
ling nevus phenotype could be such melanoma
susceptibility genes. A large Australian study involv-
ing twins aged 12 y of predominantly U.K. ancestry
showed strong evidence for genetic in¯uence on
nevus number and density. We carried out essentially
the same study in the U.K. to gain insight into gene±
environment interactions for nevi. One hundred and
three monozygous (MZ) and 118 dizygous (DZ)
twin pairs aged 10±18 y were examined in Yorkshire
and Surrey, U.K. Nevus counts were, on average,
higher in boys (mean = 98.6) than girls (83.8)
(p = 0.009) and higher in Australia (110.4) than in the
U.K. (79.2, adjusted to age 12 y, p < 0.0001), and
nevus densities were higher on sun-exposed sites
(92 per m2) than sun-protected sites (58 per m2)
(p < 0.0001). Correlations in sex and age adjusted
nevus density were higher in MZ pairs (0.94, 95%CI
0.92±0.96) than in DZ pairs (0.61, 95%CI 0.49±0.72),
were notably similar to those of the Australian study
(MZ = 0.94, DZ = 0.60), and were consistent with
high heritability (65% in the U.K., 68% in Australia).
We conclude that emergence of nevi in adolescents
is under strong genetic control, whereas environ-
mental exposures affect the mean number of
nevi. Key words: genes/heritability/melanoma/nevi/twins.
J Invest Dermatol 117:348±352, 2001
E
xposure to sunlight is the most potent environmental
risk factor for melanoma (Armstrong and Kricker,
1993). Evidence for a causal link is the overall gradation
in incidence with latitude (Armstrong and Kricker,
1994). The presence of large numbers of nevi has also
been shown to be a risk factor (Swerdlow et al, 1986; Augustsson
et al, 1990; Bataille et al, 1996) and those living at lower latitudes
may have larger numbers of nevi (Green et al, 1995; Sancho-
Garnier et al, 1997). Therefore one hypothesis is that nevi are
predominantly a marker of sun exposure (Armstrong and Kricker,
1996).
There is evidence, however, that nevi are under genetic control.
Families prone to melanoma often have large numbers of nevi, or
nevi of an atypical appearance (dysplastic) or distributed atypically
(such as on the buttocks). This phenotype is usually referred to as
the atypical mole syndrome (AMS), dysplastic nevus syndrome
(Kraemer, 1987), or FAMMM syndrome phenotype (Bergman
et al, 1992). Germline mutations associated with high penetrance
have been identi®ed in CDKN2A (Holland et al, 1995; Dracopoli
and Fountain, 1996; Harland et al, 1997) and CDK4 (Zuo et al,
1996). Detailed phenotypic studies in U.K. families showed that
whilst the atypical nevus phenotype correlated with mutation
carrier status, implying that CDKN2A is nevogenic, the correlation
was far from absolute (Wachsmuth et al, 1998; Newton Bishop
et al, 2000). It is not yet clear whether the variation in expression of
the phenotype within families is due to environmental or genetic
modi®ers.
Rare high penetrance mutations therefore exist that predispose
to melanoma and, at least in part, expression of the nevus
phenotype. It is our hypothesis that other variants controlling nevi
expression may also be low penetrance melanoma susceptibility
genes. The nevus phenotype is thus of interest as a marker of
melanoma risk and in understanding the pathogenesis of melanoma.
We have undertaken a study of nevi in teenage twins to
investigate the relative contribution of heredity and environment to
nevus number. Heritability is de®ned as the proportion of variance
explained by the additive effect of genes and thus depends on the
prevalence of relevant genetic determinants in the population, the
environmental exposures in that population, and the measuring
instrument. This study is based on a previous Australian study (Zhu
et al, 1999), in which 95% of the twins had U.K. ancestry but were
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living with much higher levels of ultraviolet (UV) light. Evidence
for the role of heredity on the nevus phenotype came from the
Australian study, which estimated that 68% of the phenotypic
variance was attributable to additive genetic factors. Because of the
marked difference in environmental exposures in the two coun-
tries, heritability of nevus count in the U.K. would be expected to
differ from heritability in Australia. By comparing our ®ndings with
those from this Australian study using the same de®nition of
phenotype, we take advantage of the differences in UV exposures
between the two continents in assessing the genetic and environ-
mental determinants underlying nevi expression in adolescence.
In the general population melanocytic nevi start to develop from
around 6 mo of life (MacKie et al, 1997). Peak numbers of nevi are
seen around 40 y of age, and in very old people nevus numbers are
small (MacKie et al, 1985). In biologic terms the process of
maturation and disappearance of nevi may correspond to the
cessation of proliferation of melanocytes and the induction of
cellular senescence, and failure of this normal process may have a
major role in the carcinogenic process for melanoma. It therefore
seems likely that there are genetic and environmental factors that
control the emergence of nevi and others that control the process of
senescence of melanocytes. Adolescents were chosen in these twin
studies as this is the time when nevi are increasing in number, and
potential confounding factors leading to nevus senescence are
unlikely to be operative. Whilst genes controlling senescence of
nevi may be of great importance with regard to carcinogenesis, our
main aim in this study was to consider genes controlling the
emergence and proliferation of nevi.
MATERIALS AND METHODS
Recruitment of twins to the study One hundred and three MZ
twin pairs and 118 DZ twin pairs between the ages of 10 and 18 y
(inclusive) (mean age 14 y 4 mo) were included in the study. Twins
were recruited via schools in the Yorkshire and Surrey regions of the
U.K. between September 1997 and September 1998. Ethical committee
approval was obtained for the study from a Multi-Regional Ethics
Committee and all Local Ethics Committees. The schools were asked to
distribute invitations to the twins attending their schools to take part in a
study looking into ``genes and moles''. With the aid of cartoons the
invitations described what the study involved and why the study was
being undertaken. A dermatologist (RW) visited the twin pairs either at
school or at home during daylight hours. In either location at least one
parent was present. Following informed consent and during these visits,
the twins had their nevi counted and answered individual questionnaires
aimed at assessing UV exposure (to be reported elsewhere). The twins
and their parent(s) were then asked to give either a 10 ml sample of
blood (n = 690) or a 5 ml mouthwash with plain tap water for DNA
analysis (n = 26).
Examination of the twins Benign melanocytic nevi were counted
on 20 body sites, including the eye (iris and conjunctivae), buttocks, and
anterior scalp, and were sized into <2 mm, 2±<5 mm, 5±<10 mm, and
> 10 mm categories using circular templates on acetate. Atypical moles
were de®ned as having all three of the following characteristics: > 5 mm
in diameter, variable in pigmentation, and irregular in outline. Sun-
protected sites were de®ned as upper arms, thighs, chest, abdomen, back,
and buttocks, while sun-exposed sites were de®ned as face, neck, lower
arms, lower legs, and dorsae of the hands and feet.
Height and weight were recorded for each individual and body surface
area calculated as:
BSA (m2) = [height (cm) 3 weight (kg)/3600]0.5.
The surface area of sun-protected versus sun-exposed skin was calculated
using a modi®cation of Wallace's rule of nines which takes account of
age. Values appropriate to a child of 15 y old were used (McLatchie,
1990). The parts of the body were taken as representing units of the
total body surface area as follows: face and neck (5.5%), lower arms and
dorsae of the hands (9%), lower legs and dorsae of feet (16.5%), chest
and abdomen (13%), back and buttocks (18%), upper arms (8%), and
thighs (18%). Therefore the total percentage of BSA in sun-exposed sites
was taken as 31%, and the total in sun-protected sites in which we
counted nevi was 57%. Twelve percent of the surface area was not
examined (posterior scalp, genitals, palms of the hands, and soles of the
feet). Nevus counts were transformed into nevus densities by dividing
the counts by the estimated body surface area (BSA) examined.
The same observer (RW) was used throughout this study in the U.K.,
to limit the effects of observer variability in counting. Unpublished data
from other studies conducted by our Department suggest that inter-
observer agreement in count is of the order of 80%, whereas agreement
for counts on the same subject at different times by one observer is of
the order of 96%. To facilitate the direct comparison with the Australian
study, the key Australian research nurse, AE, visited Leeds to develop a
uni®ed nevus counting and scoring scheme with RW. This scheme was
evaluated in the ®rst 16 twin pairs of our sample with AE and RW each
scoring both twins.
Zygosity determination Genomic DNA was extracted from blood
and sputum samples using Nucleon BACC2 DNA extraction kits
(Tepnel Life Sciences, Didsbury, U.K.) as per manufacturer guidelines or
sent to Nucleon Biosciences (Tepnel Life Sciences) for extraction.
Zygosity determination involved genotyping by PCR a ¯uorescent
multiplex consisting of six microsatellite markers. This multiplex, known
as the Second Generation Multiplex (SGM) was obtained from the
Forensic Science Service (Birmingham, U.K.). Reaction conditions are
described elsewhere (Kimpton et al, 1996). A separate ¯uorescent reac-
tion was also performed using the D9S942 microsatellite marker alone.
All ampli®cation reactions were carried out using AmpliTaqGold
polymerase (Applied Biosystems, Warrington, U.K.).
Electrophoresis was performed on an ABI377 automated DNA
sequencer (Applied Biosystems). One microliter of denatured PCR
product was loaded onto a 4.25% polyacrylamide gel (6 M urea;
Anachem). Tamra GS500 (Applied Biosystems) was run in every lane as
an internal size standard. Gel images were analyzed using Genescan 3.1
software (Applied Biosystems). Genotyping was performed using
Genotyper 2.0 software (Applied Biosystems) to assign allele sizes in
basepairs and also repeat numbers in the case of the SGM microsatellite
markers.
Zygosity determination was performed on all same-sex twin pairs (166
pairs in total) using the seven microsatellite markers. For each twin pair
sharing the same alleles at all loci the probability of dizygosity was
calculated based on observed genotypes and estimated population allele
frequencies.
Statistical analysis Analyses were performed using Stata Statistical
Software (Version 6.0, 1999, Stata, College Station, Texas). Comparisons
of means between the sexes and between sun-exposed and sun-protected
sites were made using t tests. The relationship between nevus count and
age was examined using linear regression. Comparisons were made both
for absolute nevus counts (to allow for comparison with other reported
studies) and for nevus density, as the twins were in a growth phase and
included both sexes. Where nevi of a particular type were rare, i.e., 5
mm or more in diameter, or atypical, absolute counts were used rather
than densities. Log transformations of nevus counts and densities were
used in regression analyses and structural equation modelling to produce
more normally distributed data. Log nevus counts were adjusted for age
and sex. Comparisons of correlations in nevus count or density were
performed using the Fisher transformation and assuming that the
resulting statistic had a normal distribution.
Intra-class correlations were estimated using one-way analysis of
variance. Structural equation modelling was used to estimate the additive
genetic, common environmental and residual environmental components
of variance under the assumption of no dominance variance. This was
achieved by ®tting an underlying model to the observed two-by-two
covariance matrices for the MZ and DZ twins using the MX software
(Neale et al, 1999). Each twin's phenotype (Y) is modelled as a linear
combination of three standard normally distributed latent variables,
representing additive genetic effects (A), environment shared between
the twins (C), and individual environment effects and measurement error
(E):
Y = aA + cC + eE.
As MZ twins share all their genes and DZ twins on average share half,
and under the assumption that MZ and DZ twins share environmental
effects with their cotwins to the same degree, the variance-covariance
matrices can be predicted (Fisher, 1918). Under this model the variance
for both MZ and DZ twins will be a
2 + c2 + e2, the covariance for MZ
twins will be a2 + c2 and the covariance for DZ twins will be a2/2 + c2.
The observed matrices were formed using all 206 MZ (or 236 DZ)
twins to estimate the variances, because the order of twins within a pair
is arbitrary (Sham, 1998).
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RESULTS
Our sample of 221 twin pairs was found to consist of 63 female±
female MZ, 40 male±male MZ, 25 female±female DZ, 38 male±
male DZ, and 55 female±male DZ pairs (103 MZ pairs in total, 118
DZ pairs). The probability that same sex DZ twins were incorrectly
classi®ed as MZ was estimated to be less than 0.001 for each of 100
twin pairs and less than 0.01 for the remaining three twin pairs
based on their genotypes and the allele frequencies of the markers
in this population.
Table I shows the summary of the raw data. Boys had more nevi
than girls, with a mean of 98.6 compared with 83.8 (p = 0.009). A
mean of 46.9 nevi in boys and 38.3 in girls were 2 mm or more in
diameter (p = 0.01). Ten percent of boys and 4% of girls had more
than 100 nevi of 2 mm or greater in diameter (p = 0.01). Sex
differences remained after subclassi®cation of nevus size and after
adjustment for BSA as shown in Table I.
Overall the nevus density in sun-exposed sites (mean 91.8, SD
56.5) was higher than in sun-protected sites (mean 58.1, SD 39.3, p
< 0.0001). The difference between sun-exposed and sun-protected
sites was greater for boys (mean density in sun exposed of 103 per
m2 versus 61.6 per m2 in sun protected) than for girls (82.0 per m2
versus 55.1 per m2, p < 0.0001 for testing equal difference in boys
and girls) (Table I). Furthermore, this difference was most marked
for the smallest (< 2 mm) nevi in boys with an average density of
58.9 per m2 in sun-exposed sites as compared with 28.8 per m2 in
sun-protected sites (Table I).
Table II shows the total nevus counts in boys and girls adjusted
to age 12 y. The total number of moles was related to age in boys
(p = 0.002) but not in girls (p = 0.40). In boys the number of moles
increased on average by nearly 9% each year over this age range.
There was no evidence of an increase in nevus density with age in
either sex (data not shown).
The intraclass correlation for total nevus count and density in
MZ pairs was 0.94 (95% CI 0.92±0.96) compared with 0.63 (0.52±
0.74) and 0.61 (0.49±0.72), respectively, for the DZ pairs
(Table III). The correlation estimates were higher for nevus
density of nevi smaller than 5 mm in diameter than for numbers of
large or atypical nevi. Interestingly, all correlations by nevus
category and zygosity were greater for the sun-protected sites than
for the sun-exposed sites but only the nevus count for nevi >
5 mm in dizygous twins approached signi®cance when allowing for
the number of comparisons made (p = 0.02 for the speci®c test of
DZ twins with nevi > 5 mm).
Structural equation modelling gives estimates of the additive
genetic component of variance (a2) (Table IV). A strong effect of
genes on nevus density, particularly of nevi smaller than 5 mm in
diameter, was seen overall. The estimated heritability (a2) was 65%,
with an additional 29% of the variance attributable to shared
environment (c2), for ``total nevus count''. Results for total nevus
density were similar to those for the counts. The genetic effect was
higher in sun-exposed (78%) than sun-protected sites (51%), where
the modelling suggests that there was a much greater effect (40%) of
a shared common environment contributing to the high correl-
ations observed between both types of twin.
The data on atypical nevi are dif®cult to interpret because of low
numbers seen, but it is of note that the heritability of numbers of
large and atypical nevi appears to be relatively low (16% in sun-
exposed sites and 26% in sun-protected sites for atypical nevi).
DISCUSSION
The comparison of nevus data between the U.K. and the Australian
studies showed several remarkable and consistent features. While
Australian adolescents (Zhu et al, 1999) had on average 30 more
nevi than the British after adjusting for age (Table II, p < 0.0001),
the measures of variation and covariation between individuals did
not differ. This included the correlations in nevus density between
MZ twins (0.94 in Australia, 0.94 in the U.K.) and DZ twins (0.60
in Australia, 0.61 in the U.K.) and the standard deviation of
population nevus count (62.3 vs 60.2 for males, 56.4 vs 56.6 for
females) (Tables II, III) (Zhu et al, 1999). Within each popula-
tion, additive genetic factors were estimated to be the major source
of interindividual variation in sex adjusted nevus density (an
estimated 68% of variation explained by genetic factors in Australia
and 65% in U.K.). The similarity in the estimated heritability from
the U.K. and Australian studies together with our observation of
higher heritability in sun-exposed (78%) versus sun-protected (51%)
sites is suggestive of a threshold UV level for genetic expression that
is attained in sun-exposed parts of the body even in the U.K.
Conversely, common environmental factors account for a signi®-
cant proportion (43%) of the variance in density of small nevi in
Table I. Mean raw nevus counts and densities in boys and
girls overall and in sun-exposed and sun-protected sites,
with standard deviations (SD) and the statistical
signi®cance of the nevus phenotype by sex (p value)
Boys (n = 211)
mean (SD)
Girls (n = 231)
mean (SD) p value
Number nevi < 2 mma 50.2 (26.9) 45.4 (29.7) 0.08
Nevus density < 2 mma 39.5 (20.2) 35.3 (22.1) 0.04
Number nevi 2 to < 5 mm 44.1 (36.8) 36.6 (29.1) 0.02
Nevus density 2 to < 5 mm 33.9 (26.6) 28.2 (22.0) 0.01
Number nevi > 5 mm 2.8 (3.8) 1.7 (2.4) <0.001
Number atypical nevi 1.2 (1.9) 0.8 (1.4) 0.01
Total nevus counta 98.6 (61.6) 83.8 (56.3) 0.009
Total nevus densitya 76.7 (44.4) 64.8 (42.0) 0.005
Sun-exposed
Nevus density < 2 mma 58.9 (30.7) 48.8 (27.0) <0.001
Nevus density 2 to < 5 mm 41.3 (36.6) 32.7 (26.7) 0.005
Number nevi > 5 mm 0.7 (1.4) 0.4 (0.8) 0.003
Number of atypical nevi 0.3 (0.7) 0.1 (0.4) 0.003
Total nevus densitya 103.0 (61.9) 82.0 (49.3) 0.001
Sun-protected
Nevus density < 2 mma 28.8 (17.0) 27.9 (21.9) 0.62
Nevus density 2 to < 5 mm 29.4 (22.3) 25.6 (20.7) 0.06
Number nevi > 5 mm 2.0 (2.8) 1.3 (2.0) 0.007
Number of atypical nevi 0.9 (1.6) 0.7 (1.2) 0.08
Total nevus densitya 61.6 (39.6) 55.1 (40.5) 0.09
aNevi < 2 mm measured on 199 boys and 227 girls.
Table II. Comparison of mean (Mean) and standard deviation (SD) of total nevus counts in 12-y-old twins in the
U.K. and Australia
Males Females
Mean SD n Mean SD n
Total nevi adjusted to age 12 in U.K.a 88.1 60.2 199 71.4 56.6 227
Total nevi from Australian study 113.9 62.3 356 106.9 56.4 348
aTo facilitate comparison between these two studies, the U.K. counts were adjusted to age 12 as this was the age of all the Australian twins.
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sun-protected sites, perhaps due to higher interfamilial and
individual variation in the exposure of so-called ``protected sites''.
In considering the raw nevus data we observed that there were
more nevi among this U.K. group than expected and also that there
was a relatively limited difference between the Australian and U.K.
studies given the difference in UV exposure. In a 1992 U.K. study
of 4±11 y olds, a mean of 31.3 nevi was counted (cf an estimated
79.2 in our study at age 12 y) (Pope et al, 1992). While the older
age of the twins reported here would imply more nevi, the
difference is surprising. These observations could imply that there is
a cohort of young people in the U.K. who have had more sun
exposure and are putatively at higher risk of melanoma, although it
is not possible to exclude some effect of ascertainment bias in that
the twins knew that we were interested in nevi. The same potential
bias existed in Queensland, however, and comparison with recent
population-based data there suggested little bias existed (Zhu et al,
1999).
Other characteristics of our population are in line with
previously published work. We found in males a small increase in
nevus number with age but not in nevus density, and males had
signi®cantly more nevi than females, as has been noted before
(Pope et al, 1992; English and Armstrong, 1994; Green et al, 1995;
Zhu et al, 1999). This could be either due to gender-speci®c
differences in melanocyte biology or due to behavioral differences
particularly relating to UV exposure between the sexes. We
therefore looked at the gender differences in sun-exposed and sun-
protected anatomical sites, which was most marked for smaller nevi
(< 2 mm in diameter, p < 0.001, Table I). As we had also found a
predominance of smaller (< 5 mm) nevi in sun-exposed sites
suggestive of a greater UV effect on the development of smaller
nevi, the data support the view that the higher nevus density in
males is in large part explained by the greater number of small nevi
in sun-exposed sites presumed to be due to greater recreational sun
exposure early in childhood.
Numbers of atypical nevi showed relatively low correlation
between twins, and the contribution of individual environment or
measurement error was much greater than for other nevi
(Table IV); however, as three-quarters had no more than one
atypical nevus, the distributional assumptions behind structural
equation modeling are not entirely met and the results should be
viewed with caution.
The aim of this study was to quantify the degree to which genes
and environment contribute to the variation in nevus number in
adolescents in the general population. Performing essentially
identical studies in two populations with markedly different levels
of UV exposure but similar gene pools permits comparisons both
within and between these populations. Furthermore, ensuring that
Table IV. Variance components estimates of the best ®tting model calculated using MX for log nevus densities or counts
overall and in sun-exposed and sun-protected areasc
Nevus size a2 (95% CI) c2 (95% CI) e2 (95% CI)
Nevus density < 2 mma 57.3 (38.1±81.7) 31.6 (7.3±50.4) 11.1 (8.1±15.5)
Nevus density 2 to < 5 mm 72.8 (51.6±92.9) 18.5 (0.0±39.9) 8.7 (6.4±11.9)
Nevus count > 5 mmb 50.4 (10.9±67.0) 5.4 (0.0±36.0) 44.2 (33.0±59.4)
Number atypicalb 34.8 (0.0±62.7) 16.3 (0.0±47.0) 48.9 (37.0±64.3)
Total nevus counta 62.0 (44.4±85.4) 32.6 (9.1±50.5) 5.4 (3.9±7.5)
Total nevus densitya 65.1 (46.6±89.5) 29.1 (4.5±47.8) 5.8 (4.2±8.1)
Sun-exposed
Nevus density < 2 mma 64.7 (38.3±84.0) 14.3 (0.0±38.4) 21.0 (15.5±29.0)
Nevus density 2±5 mmb 78.1 (51.3±87.2) 4.7 (0.0±30.5) 17.2 (12.8±23.5)
Nevus count > 5 mmb 40.3 (13.8±53.7) 0.0 (0.0±19.7) 59.7 (46.3±75.2)
Number atypicalb 16.4 (0.0±41.2) 9.1 (0.0±33.1) 74.5 (58.8±90.7)
Total nevus densitya 78.0 (54.7±91.7) 11.1 (0.0±34.3) 10.9 (8.0±15.1)
Sun-protected
Nevus density < 2 mma 39.8 (20.1±63.9) 43.2 (19.7±61.1) 17.0 (12.4±23.4)
Nevus density 2 to < 5 mm 67.5 (45.2±89.5) 19.8 (0.0±41.6) 12.7 (9.4±17.5)
Nevus count > 5 mmb 33.7 (0.0±63.3) 17.8 (0.0±47.3) 48.5 (36.2±64.8)
Number atypicalb 26.4 (0.0±61.2) 24.2 (0.0±50.9) 49.5 (37.3±65.2)
Total nevus densitya 50.7 (33.7±73.4) 40.2 (17.5±47.1) 9.0 (6.6±12.5)
aMeasured on 100 MZ pairs and 113 DZ pairs.
bBecause of zero values, 1 was added to the count before taking logarithms.
cThe component of variance a2 refers to the proportion due to additive genetic effects, c2 to common environmental factors, and e2 to residual environmental factors
(see text for details).
Table III. Intra-class correlations for (age and sex
adjusted) log nevus densities or counts in MZ and DZ
twins overall and in sun-exposed and sun-protected sites
Nevus size
MZ twins
(103 pairs)
Intra-class
correlation
(95% con®dence
interval)
DZ twins
(118 pairs)
Intra-class
correlation
(95% con®dence
interval)
Nevus density < 2 mma 0.87 (0.83±0.92) 0.61 (0.50±0.73)
Nevus density 2 to < 5 mm 0.91 (0.88±0.95) 0.53 (0.40±0.66)
Nevus count > 5 mmb 0.52 (0.38±0.66) 0.32 (0.15±0.48)
Number atypicalb 0.50 (0.36±0.65) 0.33 (0.17±0.50)
Total nevus counta 0.94 (0.92±0.96) 0.63 (0.52±0.74)
Total nevus densitya 0.94 (0.92±0.96) 0.61 (0.49±0.72)
Sun-exposed
Nevus density < 2 mma 0.77 (0.68±0.85) 0.48 (0.34±0.62)
Nevus density 2 to < 5 mmb 0.84 (0.78±0.89) 0.42 (0.27±0.57)
Nevus count > 5 mmb 0.44 (0.29±0.60) 0.08 (0.00±0.26)
Number atypicalb 0.27 (0.09±0.45) 0.17 (0.00±0.34)
Total nevus densitya 0.88 (0.84±0.93) 0.50 (0.36±0.64)
Sun-protected
Nevus density < 2 mma 0.82 (0.75±0.88) 0.63 (0.51±0.74)
Nevus density 2 to < 5 mm 0.87 (0.83±0.92) 0.52 (0.38±0.65)
Nevus count > 5 mmb 0.48 (0.33±0.63) 0.36 (0.20±0.52)
Number atypicalb 0.50 (0.35±0.64) 0.37 (0.22±0.53)
Total nevus densitya 0.91 (0.88±0.94) 0.64 (0.53±0.75)
aMeasured on 100 MZ pairs and 113 DZ pairs.
bBecause of zero values, 1 was added to the count before taking logarithms.
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the phenotypic measurements in the two studies were comparable
allowed clearer interpretation of the results. The Queensland study
provided strong evidence for the role of genetic factors but left
open a number of hypotheses. We considered three separate
hypotheses: (1) a simple model of gene±environment interaction,
such that within each population environmental exposures affect
almost uniformly each person's number of nevi where genetic
factors are the major cause of variation between individuals
(predicting observations essentially in line with those we observed);
(2) an hypothesis that such genetic factors could only be revealed in
the presence of high levels of UV exposure so that in the U.K.
lower levels of UV might not be suf®cient to express such strong
genetic variation (which would be evidenced by a lower estimated
additive genetic variance for the U.K.); and (3) the hypothesis that
individuals would vary markedly in their response to UV exposure
depending on their genetic make-up (which would be indicated by
differing extent of variation in the number of nevi in the U.K. as
compared with Australia). Whereas formal tests of such hypotheses
are not possible, our data are clearly consistent with genes and
environment acting separately and are inconsistent with the
hypothesis that U.K. UV exposure fails to reach the appropriate
critical level. Although the hypothesis of differential sensitivity to
UV (in terms of nevus density) cannot be excluded, the similarities
in the components of variation between the two studies suggest that
such interactions are limited.
In summary, we have demonstrated a major effect of genes in
controlling the emergence of nevi in adolescents. There was a
demonstrable effect of sun exposure on the average expression of
these genes, particularly nevi on sun-exposed body sites, but the
major determinant of variation appears to be genetic.
This research was funded by the Imperial Cancer Research Fund and the NHS
R&D Executive, Northern and Yorkshire Region. Our thanks to Mrs Bette Ward
and Zoe Kennedy, for skilful assistance with administration and data entry for the
study.
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